Companies / Japan
Sanofi-Aventis Pledges Japan Expansion
April 2006 | Company Finance AlertFrench drug major Sanofi-Aventis is to expand in Japan and make the market a 'priority' over the next few years. The announcement follows the company's decision to reassume exclusive local rights to its anti-obesity compound Acomplia, which is awaiting approval in Japan and the US. Reports claim that the company will aggressively market blockbuster blood thinner Plavix (clopidogrel) to boost
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
